Obese boys at increased risk for nonalcoholic liver disease: Evaluation of 16 390 overweight or obese children and adolescents

International Journal of Obesity

Volumn 34, Issue 10, 2010, Pages 1468-1474

  Wiegand, S ^a   Keller, K M ^b   Robl M ^c   L'Allemand, D ^d   Reinehr, T ^e   Widhalm, K ^f   Holl, R W ^g  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Children's Hospital of Eastern Switzerland   (Switzerland)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY OF ULM   (Germany)

Author keywords

childhood obesity; gender; metabolic syndrome; nonalcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ARTICLE; AUSTRIA; BODY MASS; CHILD; CHILDHOOD DISEASE; COMORBIDITY; COMPUTER PROGRAM; FEMALE; GERMANY; HUMAN; HYPERTRANSAMINASEMIA; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SWITZERLAND;

ADOLESCENT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; AUSTRIA; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY LIVER; FEMALE; GERMANY; HUMANS; INFANT; MALE; OBESITY; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SWITZERLAND;

EID: 77957903136     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.106     Document Type: Article

References (42)

1. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006; 1: 11-25.
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374.
3. Baranowski T, Cooper DM, Harrell J, Hirst K, Kaufman FR, Goran M et al. Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care 2006; 29: 212-217.
4. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Gruters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity\a problem that is no longer restricted to minority groups. Eur J Endocrinol 2004; 151: 199-206.
5. I'Allemand D, Wiegand S, Reinehr T, Müller J, Wabitsch M, Widhalm K et al. Cardiovascular risk in 26008 European overweight children as established by a multicenter database. Obesity (Silver Spring) 2008; 16: 1672-1679.
6. Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 1983; 78: 374-377.
7. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 2006; 43: 413-427.
8. De Lèdinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J et al. Liver stiffness measurement in children with fibroscan. Feasibility study and comparison with fibrotest, aspartate trans-aminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007; 45: 443-450.
9. Patton HM, Lavine JE, Van Natta ML, Schwimmer JB, Kleiner D, Molleston J. Nonalcoholic Steatohepatitis Clinical Research Network. Clinical correlates of histopathology in pediatric non-alcoholic steatohepatitis. Gastroenterology 2008; 135: 1961-1971.
10. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 2007; 133: 1814-1820.
11. van Vliet M, von Rosenstiel IA, Schindhelm RK, Brandjes DP, Beijnen JH, Diamant M. The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin. Eur J Pediatr 2009; 168: 585-591.
12. Wedemeyer H, Hofmann WP, Lueth S, Malinski P, Thimme R, Tacke F et al. ALT als Screeningparameter für Lebererkrankungen: eine kritische Evaluation der Evidenz. ALT screening for chronic liver diseases: scrutinizing the evidence. Z Gastroenterol 2010; 48: 46-55
13. Guidelines of the German Working Group of Childhood obesity. Available from www.a-g-a.de.
14. Reinehr T, Wabitsch M, Andler W, Beyer P, Bottner A, Chen-Stute A et al. Medical care of obese children and adolescents. APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients trans-ferred to specialised treatment institutions. Eur J Pediatr 2004; 163: 308-312.
15. Kromeyer-Hauschild K, Wabitsch M, Kunze D. Perzentile für den Body-mass-Index für das Kindes-und Jugendalter unter Heran-ziehung verschiedener deutscher Stichproben. Monatsschr Kinder-heilk 2001; 149: 807-818.
16. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
17. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45-60.
18. de Man SA, André JL, Bachmann H, Grobbee DE, Ibsen KK, Laaser U et al. Blood pressure in childhood: pooled findings of six European studies. JHypertens 1991; 9: 109-114.
19. Kavey REW, Daniels SR, Lauer RM, Atins DL, Hayman LL, Taubert K American Heart Association Guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 2003; 107: 1562-1566.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
21. Dmitrienko EA. Analysis of Clinical Trials Using SAS. SAS Press: Cary, NC, 2005.
22. Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr 1997; 24: 317-321.
23. Manton ND, Lipsett J, Moore DJ, Davidson GP, Bourne AJ, Couper RT. Non-alcoholic steatohepatitis in children and adolescents. Med J Aust 2000; 173: 476-479.
24. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428-1432.
25. Nobili V, Reale A, Alisi A, Morino G, Trenta I, Pisani M et al. Elevated serum ALT in children presenting to the emergency unit: relationship with NAFLD. Dig Liver Dis 2009; 41: 749-752.
26. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393.
27. Di Bonito P, Sanguigno E, Di Fraia T, Forziato C, Boccia G, Saitta F et al. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis. Metabolism 2009; 58: 368-372.
28. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004; 328: 983.
29. A-Kader HH, Henderson J, Vanhoesen K, Ghishan F, Bhattacharyya A. Nonalcoholic fatty liver disease in children: a single center experience. Clin Gastroenterol Hepatol 2008; 6: 799-802.
30. Roberts EA. Pediatric nonalcoholic fatty liver disease (NAFLD): a 'growing' problem? J Hepatol 2007; 46: 1133-1142.
31. Schwimmer JB, Khorram O, Chiu V, Schwimmer WB. Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertil Steril 2005; 83: 494-497.
32. Brzozowska MM, Ostapowicz G, Weltman MD. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol 2009; 24: 243-247.
33. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-1657.
34. Anezaki Y, Ohshima S, Ishii H, Kinoshita N, Dohmen T, Kataoka E et al. Sex difference in the liver of hepatocyte-specific Pten-deficient mice: a model of nonalcoholic steatohepatitis. Hepatol Res 2009; 39: 609-618.
35. Reinehr T, Toschke AM. Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study. Arch Pediatr Adolesc Med 2009; 163: 709-715.
36. Reinehr T, Schmidt C, Toschke AM, Andler W. Lifestyle inter-vention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch Dis Child 2009; 94: 437-442.
37. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006; 40: S17-S29.
38. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112.
39. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008; 32: 381-387.
40. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006; 91: 4287-4294.
41. Denzer C, Thiere D, Muche R, Koenig W, Mayer H, Kratzer Wet al. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 2009; 94: 3872-3881.
42. Kleiser C, Schaffrath Rosario A, Mensink GB, Prinz-Langenohl R, Kurth BM. Potential determinants of obesity among children and adolescents in Germany: results from the cross-sectional KiGGS Study. BMC Public Health 2009; 2: 9-46.